
COMMISSION DIRECTIVE 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance) 

THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances, and in particular Article 28 thereof,
Whereas:

(1) Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.

(2) Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.

(3) Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.

(4) Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.

(5) Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.

(6) The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.

(7) As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.

(8) The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.

(9) The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,
HAS ADOPTED THIS DIRECTIVE:

Article 1 
Directive 67/548/EEC is amended as follows. Annex I is amended as follows:

((a)) the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;
((b)) the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;
((c)) the entries set out in Annex 1C to this Directive are deleted.
Article 2 
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
Article 3 
This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Article 4 
This Directive is addressed to the Member States.
Done at Brussels, 15 January 2009.
For the Commission
Stavros DIMAS
Member of the Commission
ANNEX 1A

Index No Chemical name Notes related to substances EC No CAS No Classification Labelling Concentration Limits Notes related to preparations
001-002-00-4 aluminium lithium hydride  240-877-9 16853-85-3 F; R15C; R35 F; CR: 15-35S: (1/2-)7/8-26-36/37/39-43-45  
005-006-00-7 dibutyltin hydrogen borate E 401-040-5 75113-37-0 Muta. Cat. 3; R68Repr. Cat. 2; R60-61T; R48/25Xn; R21/22Xi; R41R43N; R50-53 T; NR: 60-61-21/22-41-43-48/25-68-50/53S: 53-45-60-61  
006-007-00-5 salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex A — — T+; R26/27/28R32N; R50-53 T+; NR: 26/27/28-32-50/53S: (1/2-)7-28-29-45-60-61  
006-015-00-9 diuron (ISO);3-(3,4-dichlorophenyl)-1,1-dimethylurea  206-354-4 330-54-1 Carc. Cat. 3; R40Xn; R22-48/22N; R50-53 Xn; NR: 22-40-48/22-50/53S: (2-)13-36/37-46-60-61 C ≥ 25 %: Xn, N; R22-40-48/22-50/5310 % ≤ C < 25 %: Xn, N; R40-48/22-50/532,5 % ≤ C < 10 %: Xn, N; R40-50/531 % ≤ C < 2,5 %: Xn, N; R40-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
006-076-00-1 mancozeb (ISO);manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt  — 8018-01-7 Repr. Cat. 3; R63R43N; R50 Xn; NR: 43-63-50S: (2-)36/37-46-61 C ≥ 5 %: Xn, N; R43-63-502,5 ≤ C < 5 %: Xi, N; R43-501 % ≤ C < 2,5 %: Xi; R43 
006-077-00-7 maneb (ISO);manganese ethylenebis(dithiocarbamate) (polymeric)  235-654-8 12427-38-2 Repr. Cat. 3; R63Xn; R20Xi; R36R43N; R50-53 Xn; NR: 20-36-43-63-50/53S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R20-36-43-63-50/5320 % ≤ C < 25 %: Xn, N; R36-43-63-50/535 % ≤ C < 20 %: Xn, N; R43-63-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
006-084-00-5 carbosulfan (ISO);2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate  259-565-9 55285-14-8 T+; R26T; R25R43N; R50-53 T+; NR: 25-26-43-50/53S: (1/2-)28-36/37-38-45-63-60-61  
006-088-00-7 benfuracarb (ISO);ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate  — 82560-54-1 Repr. Cat. 3; R62T; R23Xn; R22N; R50-53 T; NR: 22-23-62-50/53S: (1/2-)36/37-45-60-61  
007-002-00-0 nitrogen dioxide; [1]dinitrogen tetraoxide [2]  233-272-6 [1]234-126-4 [2] 10102-44-0 [1]10544-72-6 [2] O; R8T+; R26C; R34 O; T+R: 8-26-34S: (1/2-)9-26-28-36/37/39-45 C ≥ 10 %: T+; R26-345 % ≤ C < 10 %: T; R23-341 % ≤ C < 5 %: T; R23-36/37/380,5 % ≤ C < 1 %: Xn; R20-36/37/380,1 % ≤ C < 0,5 %: Xn; R20 5
015-041-00-X malathion (ISO);1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;[containing ≤ 0,03 % isomalathion]  204-497-7 121-75-5 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-46-60-61 C ≥ 25 %: Xn, N; R22-43-50/531 % ≤ C < 25 %: Xi, N; R43-50/530,025 % ≤ C < 1 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53 
015-100-00-X phoxim (ISO);α-(diethoxyphosphinothioylimino) phenylacetonitrile  238-887-3 14816-18-3 Repr. Cat. 3; R62Xn; R22R43N; R50-53 Xn; NR: 22-43-62-50/53S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R22-43-62-50/535 % ≤ C < 25 %: Xn, N; R43-62-50/531 % ≤ C < 5 %: Xi, N; R43-50/530,025 % ≤ C < 1 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53 
015-102-00-0 tris(2-chloroethyl)phosphate E 204-118-5 115-96-8 Carc. Cat. 3; R40Repr. Cat. 2; R60Xn; R22N; R51-53 T; NR: 60-22-40-51/53S: 53-45-61  
015-155-00-X glufosinate ammonium (ISO);ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate E 278-636-5 77182-82-2 Repr. Cat. 2; R60Repr. Cat. 3; R63Xn; R20/21/22-48/20/22 TR: 60-20/21/22-48/20/22-63S: 53-45  
016-009-00-8 disodium sulfide;sodium sulfide  215-211-5 1313-82-2 T; R24Xn; R22C; R34R31N; R50 T; C; NR: 22-24-31-34-50S: (1/2-)26-36/37/39-45-61  
017-009-00-0 ammonium perchlorate;[containing ≥ 80 % of 0-30 μm particles] T 232-235-1 7790-98-9 E; R3O; R9 ER: 3-9S: (2-)14-16-36/37  
024-004-00-7 sodium dichromate E 234-190-3 10588-01-9 O; R8Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23Xn; R21C; R34R42/43N; R50-53 O; T+; NR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53S: 53-45-60-61 C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/5310 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/537 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/535 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/533 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/532,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/531 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/530,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/530,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/530,2 % ≤ C < 0,25 %: T; R45-46-20-42/430,1 % ≤ C < 0,2 %: T; R45-46-20 3
027-002-00-4 cobalt oxide  215-154-6 1307-96-6 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61 C ≥ 25 %: Xn, N; R22-43-50/532,5 % ≤ C < 25 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
027-003-00-X cobalt sulfide  215-273-3 1317-42-6 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61 C ≥ 2,5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
028-003-00-2 nickel monoxide; [1]nickel oxide; [2]bunsenite [3] E 215-215-7 [1]234-323-5 [2]- [3] 1313-99-1 [1]11099-02-8 [2]34492-97-2 [3] Carc. Cat. 1; R49T; R48/23R43R53 TR: 49-43-48/23-53S: 53-45-61  
028-004-00-8 nickel dioxide E 234-823-3 12035-36-8 Carc. Cat. 1; R49T; R48/23R43R53 TR: 49-43-48/23-53S: 53-45-61  
028-005-00-3 dinickel trioxide E 215-217-8 1314-06-3 Carc. Cat. 1; R49T; R48/23R43R53 TR: 49-43-48/23-53S: 53-45-61  
028-006-00-9 nickel (II) sulfide; [1]nickel sulfide; [2]millerite [3] E 240-841-2 [1]234-349-7 [2]- [3] 16812-54-7 [1]11113-75-0 [2]1314-04-1 [3] Carc. Cat. 1; R49Muta. Cat. 3; R68T; R48/23R43N; R50-53 T; NR: 49-43-48/23-68-50/53S: 53-45-60-61  
028-007-00-4 trinickel disulfide;nickel subsulfide; [1]heazlewoodite [2] E 234-829-6 [1]- [2] 12035-72-2 [1]12035-71-1 [2] Carc. Cat. 1; R49Muta. Cat. 3; R68T; R48/23R43N; R50-53 T; NR: 49-43-48/23-68-50/53S: 53-45-60-61  
028-008-00-X nickel dihydroxide; [1]nickel hydroxide [2] E 235-008-5 [1]234-348-1 [2] 12054-48-7 [1]11113-74-9 [2] Carc. Cat. 1; R49Repr. Cat. 2; R61Muta. Cat. 3; R68T; R48/23Xn; R20/22Xi; R38R42/43N; R50-53 T; NR: 49-61-20/22-38-42/43-48/23-68-50/53S: 53-45-60-61  
029-013-00-X trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)  407-580-8 130201-51-3 Xi; R41 XiR: 41S: (2-)26-39  
033-005-00-1 arsenic acid and its salts with the exception of those specified elsewhere in this Annex AE — — Carc. Cat. 1; R45T; R23/25N; R50-53 T; NR: 45-23/25-50/53S: 53-45-60-61  
034-002-00-8 selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex A — — T; R23/25R33N; R50-53 T; NR: 23/25-33-50/53S: (1/2-)20/21-28-45-60-61  
047-001-00-2 silver nitrate  231-853-9 7761-88-8 O; R8C; R34N; R50-53 O; C; NR: 8-34-50/53S: (1/2-)26-36/37/39-45-60-61  
050-002-00-0 cyhexatin (ISO);hydroxytricyclohexylstannane;tri(cyclohexyl)tin hydroxide  236-049-1 13121-70-5 Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61 C ≥ 25 %: Xn, N; R20/21/22-50/530,025 % ≤ C < 25 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53 
050-003-00-6 fentin acetate (ISO);triphenyltin acetate  212-984-0 900-95-8 Carc. Cat. 3; R40Repr. Cat. 3; R63T+; R26T; R24/25-48/23Xi; R37/38-41N; R50-53 T+; NR: 24/25-26-37/38-40-41-48/23-63-50/53S: (1/2-)26-28-36/37/39-45-60-61 C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/5320 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/5310 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/537 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/535 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/533 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/532,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/531 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/530,25 % ≤ C < 1 %: Xn, N; R20-51/530,1 % ≤ C < 0,25 %: Xn; R20-52/530,025 % ≤ C < 0,1 %: R52/53 
050-004-00-1 fentin hydroxide (ISO);triphenyltin hydroxide  200-990-6 76-87-9 Carc. Cat. 3; R40Repr. Cat. 3; R63T+; R26T; R24/25-48/23Xi; R37/38-41N; R50-53 T+; NR: 24/25-26-37/38-40-41-48/23-63-50/53S: (1/2-)26-28-36/37/39-45-60-61 C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/5320 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/5310 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/537 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/535 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/533 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/532,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/531 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/530,25 % ≤ C < 1 %: Xn, N; R20-51/530,1 % ≤ C < 0,25 %: Xn; R20-52/530,025 % ≤ C < 0,1 %: R52/53 
050-008-00-3 tributyltin compounds, with the exception of those specified elsewhere in this Annex A — — T; R25-48/23/25Xn; R21Xi; R36/38N; R50-53 T; NR: 21-25-36/38-48/23/25-50/53S: (1/2-)36/37/39-45-60-61 C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/531 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/530,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/530,025 % C < 0,25 %: R52/53 1
050-011-00-X triphenyltin compounds, with the exception of those specified elsewhere in this Annex A — — T; R23/24/25N; R50-53 T; NR: 23/24/25-50/53S: (1/2-)26-27-28-45-60-61 C ≥ 1 %: T, N; R23/24/25-50/530,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 % ≤ C < 0,025 %: R52/53 1
050-018-00-8 tin(II) methanesulphonate  401-640-7 53408-94-9 C; R34Xn; R22R43N; R51-53 C; NR: 22-34-43-51/53S: (1/2-)22-26-36/37/39-45-61  
053-003-00-4 iodoxybenzene  — 696-33-3 E; R2 ER: 2S: (2-)35  
053-004-00-X calcium iodoxybenzoate C — — E; R2 ER: 2S: (2-)35  
080-001-00-0 mercury E 231-106-7 7439-97-6 Repr. Cat. 2; R61T+; R26T; R48/23N; R50-53 T+; NR: 61-26-48/23-50/53S: 53-45-60-61  
080-010-00-X mercury dichloride;mercuric chloride  231-299-8 7487-94-7 Muta. Cat. 3; R68Repr. Cat. 3; R62T+; R28T; R48/24/25C; R34N; R50-53 T+; NR: 28-34-48/24/25-62-68-50/53S: (1/2-)26-36/37/39-45-60-61  
092-002-00-3 uranium compounds with the exception of those specified elsewhere in this Annex A — — T+; R26/28R33N; R51-53 T+; NR: 26/28-33-51/53S: (1/2-)20/21-45-61  
601-065-00-3 A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane)  416-930-9 — Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)36/37-61  
602-007-00-X bromoform;tribromomethane  200-854-6 75-25-2 T; R23Xn; R22Xi; R36/38N; R51-53 T; NR: 22-23-36/38-51/53S: (1/2-)28-45-63-61  
602-030-00-5 1,3-dichloropropene; [1](Z)-1,3-dichloropropene [2] C D 208-826-5 [1]233-195-8 [2] 542-75-6 [1]10061-01-5 [2] R10T; R24/25Xn; R20-65Xi; R36/37/38R43N; R50-53 T; NR: 10-20-24/25-36/37/38-43-65-50/53S: (1/2-)36/37-45-60-61  
602-054-00-6 3-iodpropene;allyl iodide  209-130-4 556-56-9 F; R11C; R34 F; CR: 11-34S: (1/2-)7-16-26-45  
603-005-00-1 2-methylpropan-2-ol;tert-butyl alcohol  200-889-7 75-65-0 F; R11Xn; R20Xi; R36/37 F; XnR: 11-20-36/37S: (2-)9-16-46  
603-018-00-2 furfuryl alcohol  202-626-1 98-00-0 Carc. Cat. 3; R40T; R23Xn; R21/22-48/20Xi; R36/37 TR: 21/22-23-36/37-40-48/20S: (1/2-)36/37-45-63  
603-023-00-X ethylene oxide;oxirane E 200-849-9 75-21-8 F+; R12R6Carc. Cat. 2; R45Muta. Cat. 2; R46T; R23Xi; R36/37/38 F+; TR: 45-46-6-12-23-36/37/38S: 53-45  
603-029-00-2 bis(2-chloroethyl) ether  203-870-1 111-44-4 Carc. Cat. 3; R40T+; R26/27/28 T+R: 26/27/28-40S: (1/2-)7/9-27-28-36/37-45 C ≥ 7 %: T+; R26/27/28-401 % ≤ C < 7 %: T; R23/24/25-400,1 % ≤ C < 1 %: Xn; R20/21/22 
603-037-00-6 cellulose nitrate;nitrocellulose T — — E; R3 ER: 3S: (2-)35  
603-046-00-5 bis(chloromethyl) ether;oxybis(chloromethane) E 208-832-8 542-88-1 F; R11Carc. Cat. 1; R45T+; R26T; R24Xn; R22 F; T+R: 45-11-22-24-26S: 53-45 C ≥ 25 %: T+; R45-22-24-267 % ≤ C < 25 %: T+; R45-21-263 % ≤ C < 7 %: T; R45-21-231 % ≤ C < 3 %: T; R45-230,1 % ≤ C < 1 %: T; R45-200,001 % ≤ C < 0,1 %: T; R45 
603-064-00-3 1-methoxy-2-propanol;monopropylene glycol methyl ether  203-539-1 107-98-2 R10R67 R: 10-67S: (2-)  
603-066-00-4 1,2-epoxy-4-epoxyethylcyclohexane;4-vinylcyclohexene diepoxide  203-437-7 106-87-6 Carc. Cat. 3; R40T; R23/24/25 TR: 23/24/25-40S: (1/2-)36/37-45-63 C ≥ 1 %: T; R23/24/25-400,1 % ≤ C < 1 %: Xn; R20/21/22 
605-004-00-1 2,4,6-trimethyl-1,3,5-trioxane;paraldehyde  204-639-8 123-63-7 R10 R: 10S: (2-)29  
605-005-00-7 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;metaldehyde  203-600-2 108-62-3 F; R11Xn; R22 F; XnR: 11-22S: (2-)13-16-25-46  
606-021-00-7 N-methyl-2-pyrrolidone;1-methyl-2-pyrrolidone  212-828-1 872-50-4 Repr. Cat. 2; R61Xi; R36/37/38 TR: 61-36/37/38S: 53-45 C ≥ 10 %: T; R61-36/37/385 % ≤ C < 10 %: T; R61 
607-007-00-3 salts of oxalic acid with the exception of those specified elsewhere in this Annex A — — Xn; R21/22 XnR: 21/22S: (2-)24/25 C ≥ 5 %: Xn; R21/22 
607-012-00-0 benzoyl chloride  202-710-8 98-88-4 Xn; R20/21/22C; R34R43 CR: 20/21/22-34-43S: (1/2-)26-36/37/39-45  
607-037-00-7 2-ethoxyethyl acetate;ethylglycol acetate E 203-839-2 111-15-9 R10Repr. Cat. 2; R60-61Xn; R20/21/22 TR: 60-61-10-20/21/22S: 53-45  
607-051-00-3 MCPA (ISO);4-chloro-o-tolyloxyacetic acid  202-360-6 94-74-6 Xn; R22Xi; R38-41N; R50-53 Xn; NR: 22-38-41-50/53S: (2-)26-37-39-60-61  
607-052-00-9 salts and esters of MCPA A — — Xn; R20/21/22N; R50-53 Xn; NR: 20/21/22-50/53S: (2-)13-60-61  
607-085-00-9 benzyl benzoate  204-402-9 120-51-4 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)25-46-61  
607-095-00-3 maleic acid  203-742-5 110-16-7 Xn; R22Xi; R36/37/38R43 XnR: 22-36/37/38-43S: (2-)24-26-28-37-46 C ≥ 25 %: Xn; R22-36/37/38-4320 % ≤ C <25 %: Xi; R36/37/38-430,1 % ≤ C < 20 %: Xi; R43 
607-103-00-5 succinic anhydride  203-570-0 108-30-5 Xn; R22Xi; R36/37 XnR: 22-36/37S: (2-)25-46 C ≥ 5 %: Xn; R22-36/371 % ≤ C < 5 %: Xi; R36/37 
607-142-00-8 propyl chloroformate;chloroformic acid propylester;n-propyl chloroformate  203-687-7 109-61-5 F; R11T; R23C; R34 F; TR: 11-23-34S: (1/2-)16-26-36-45  
607-195-00-7 2-methoxy-1-methylethyl acetate  203-603-9 108-65-6 R10 R: 10S: (2-)  
607-216-00-X glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine  403-950-8 — T+; R26Xn; R22C; R34N; R50 T+; NR: 22-26-34-50S: (1/2-)26-36/37/39-38-45-61  
607-231-00-1 clopyralid (ISO);3,6-dichloropyridine-2-carboxylic acid  216-935-4 1702-17-6 Xi; R41 XiR: 41S: (2-)26-39  
607-245-00-8 tert-butyl acrylate D 216-768-7 1663-39-4 F; R11Xn; R20/21/22Xi; R37/38R43N; R51-53 F; Xn; NR: 11-20/21/22-37/38-43-51/53S: (2-)16-25-37-61 C ≥ 25 %: Xn; R20/21/22-37/38-43-51/5320 % ≤ C < 25 %: Xi; R37/38-43-52/532,5 % ≤ C < 20 %: Xi; R43-52/531 % ≤ C < 2,5 %: Xi; R43 
607-397-00-5 A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated);Ca phenates (branched C10-14 and C18-30 alkylated);Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)  415-930-6 — Repr. Cat. 3; R62R43 XnR: 43-62S: (2-)23-36/37  
608-005-00-5 n-butyronitrile  203-700-6 109-74-0 F; R11T; R23/24/25 F; TR: 11-23/24/25S: (1/2-)16-36/37-45-63  
608-011-00-8 oxalonitrile;cyanogen  207-306-5 460-19-5 F+; R12T; R23N; R50-53 F+; T; NR: 12-23-50/53S: (1/2-)9-16-23-33-45-63-60-61  
608-044-00-8 2-cyclohexylidene-2-phenylacetonitrile  423-740-1 10461-98-0 Xn; R22N; R51-53 Xn; NR; 22-51/53S: (2-)46-61  
609-007-00-9 2,4-dinitrotoluene; [1]dinitrotoluene [2] E 204-450-0 [1]246-836-1 [2] 121-14-2 [1]25321-14-6 [2] Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22N; R50-53 T; NR: 45-23/24/25-48/22-62-68-50/53S: 53-45-60-61  
611-028-00-3 C,C′-azodi(formamide)  204-650-8 123-77-3 E; R2R42 E; XnR: 2-42S: (2-)22-24-37  
611-035-00-1 tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate  403-660-1 107246-80-0 N; R51-53 NR: 51/53S: 61  
612-044-00-3 N,N′-diacetylbenzidine E 210-338-2 613-35-4 Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R20/21/22 TR: 45-20/21/22-68S: 53-45  
612-050-00-6 cyclohexylamine  203-629-0 108-91-8 R10Repr. Cat. 3; R62Xn; R21/22C; R34 CR: 10-21/22-34-62S: (1/2-)26-36/37/39-45 C ≥ 25 %: C; R21/22-34-6210 % ≤ C < 25 %: C; R34-625 % ≤ C < 10 %: Xn; R36/38-622 % ≤ C < 5 %: Xi; R36/38 
612-076-00-8 ethyldimethylamine  209-940-8 598-56-1 F; R11Xn; R20/22C; R34 F; CR: 11-20/22-34S: (1/2-)3-16-26-36-45  
612-099-00-3 4-methyl-m-phenylenediamine;2,4-toluenediamine E 202-453-1 95-80-7 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R25Xn; R21-48/22R43N; R51-53 T; NR: 45-21-25-43-48/22-62-68-51/53S: 53-45-61  
612-101-00-2 methenamine;hexamethylenetetramine  202-905-8 100-97-0 F; R11R43 F; XiR: 11-43S: (2-)24-37  
612-151-00-5 methyl-phenylene diamine;diaminotoluene;[technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)] E — — Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R25Xn; R21-48/22Xi; R36R43N; R51-53 T; NR: 45-21-25-36-43-48/22-62-68-51/53S: 53-45-61  
612-237-00-2 hydroxylammonium hydrogensulfate;hydroxylamine sulfate(1:1); [1]hydroxylamine phosphate; [2]hydroxylamine dihydrogenphosphate; [3]hydroxylamine 4-methylbenzenesulfonate [4] T 233-154-4 [1]244-077-0 [2]242-818-2 [3]258-872-5 [4] 10046-00-1 [1]20845-01-6 [2]19098-16-9 [3]53933-48-5 [4] E; R2Carc. Cat. 3; R40Xn; R21/22-48/22Xi; R36/38R43N; R50 E; Xn; NR: 21/22-36/38-40-43-48/22-50S: (2-)36/37-61  
613-116-00-7 tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]  211-986-9 731-27-1 T+; R26T; R48/23Xi; R36/37/38R43N; R50 T+; NR: 26-36/37/38-43-48/23-50S: (1/2-)28-36/37/39-45-63-61 C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-5010 % ≤ C < 20 %: T+, N; R26-43-48/23-507 % ≤ C < 10 %: T+, N; R26-43-48/20-502,5 % ≤ C < 7 %: T, N; R23-43-48/20-501 % ≤ C < 2,5 %: T; R23-43-48/200,1 % ≤ C < 1 %: Xn; R20 
615-001-00-7 methyl isocyanate  210-866-3 624-83-9 F; R11Repr. Cat. 3; R63T+; R26T; R24/25R42/43Xi; R37/38-41 F; T+R: 11-24/25-26-37/38-41-42/43-63S: (1/2-)16-26-27/28-36/37/39-45-63  
615-004-00-3 salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex A — — Xn; R20/21/22R32R52-53 XnR: 20/21/22-32-52/53S: (2-)13-36/37-46-61  
615-028-00-4 ethyl 2-(isocyanatosulfonyl)benzoate  410-220-2 77375-79-2 R14Xn; R22-48/22Xi; R41R42/43 XnR: 14-22-41-42/43-48/22S: (2-)8-23-26-30-35-36/37/39  
615-030-00-5 alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex A — — Xn; R20/21/22R32R52-53 XnR: 20/21/22-32-52/53S: (2-)13-36/37-46-61  
615-031-00-0 thallium thiocyanate  222-571-7 3535-84-0 T+; R26/28Xn; R21R32R33N; R51-53 T+; NR: 21-26/28-32-33-51/53S: (1/2-)13-28-36/37-45-61  
615-032-00-6 metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex A — — Xn; R20/21/22R32N; R50-53 Xn; NR: 20/21/22-32-50/53S: (2-)13-36/37-46-60-61  
616-124-00-9 lithium bis(trifluoromethylsulfonyl)imide  415-300-0 90076-65-6 T; R24/25Xn; R48/22C; R34R52-53 TR: 24/25-34-48/22-52/53S: (1/2-)22-26-36/37/39-45-61  
617-017-00-X A mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene;2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzene T 412-140-3 32144-25-5 E; R2O; R7R53 ER: 2-7-53S: (2-)3/7-14-36/37/39-61  
650-016-00-2 Mineral wool, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight] AQR — — Carc. Cat. 3; R40 XnR: 40S: (2-)36/37  
650-017-00-8 Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight] AR — — Carc. Cat. 2; R49 TR: 49S: 53-45  
ANNEX 1B

Index No Chemical name Notes related to substances EC No CAS No Classification Labelling Concentration Limits Notes related to preparations
003-003-00-5 (2-methylpropyl)lithium;isobutyllithium  440-620-2 920-36-5 F; R15-17R14C; R35R67N; R50-53 F; C; NR: 14/15-17-35-67-50/53S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61  
005-013-00-5 diethylmethoxyborane  425-380-9 7397-46-8 F; R17Xn; R20/21/22-48/22C; R34R43R53 F; CR: 17-20/21/22-34-43-48/22-53S: (1/2-)6-26-36/37/39-43-45-61  
005-014-00-0 4-formylphenylboronic acid  438-670-5 87199-17-5 R43 XiR: 43S: (2-)24-37  
005-017-00-7 sodium perborate; [1]perboric acid, sodium salt; [2]perboric acid, sodium salt, monohydrate; [3]sodium peroxometaborate; [4]perboric acid (HBO(O2)), sodium salt, monohydrate; [5]sodium peroxoborate;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E 239-172-9 [1]234-390-0 [2]- [3]231-556-4 [4]- [5] 15120-21-5 [1]11138-47-9 [2]12040-72-1 [3]7632-04-4 [4]10332-33-9 [5] O; R8Repr. Cat. 2; R61Repr. Cat. 3; R62Xn; R22Xi; R37-41 O; TR: 61-8-22-37-41-62S: 53-45 C ≥ 25 %: T; R61-22-37-41-6222 % ≤ C < 25 %: T; R61-37-41-6220 % ≤ C < 22 %: T; R61-36/37-6214 % ≤ C < 20 %: T; R61-36-629 % ≤ C < 14 %: T; R61-626,5 % ≤ C < 9 %: T; R61 
005-017-01-4 sodium perborate; [1]perboric acid, sodium salt; [2]perboric acid, sodium salt, monohydrate; [3]sodium peroxometaborate; [4]perboric acid (HBO(O2)), sodium salt, monohydrate; [5]sodium peroxoborate;[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E 239-172-9 [1]234-390-0 [2]- [3]231-556-4 [4]- [5] 15120-21-5 [1]11138-47-9 [2]12040-72-1 [3]7632-04-4 [4]10332-33-9 [5] O; R8Repr. Cat. 2; R61Repr. Cat. 3; R62T; R23Xn; R22Xi; R37-41 O; TR: 61-8-22-23-37-41-62S: 53-45 C ≥ 25 %: T; R61-22-23-37-41-6222 % ≤ C < 25 %: T; R61-20-37-41-6220 % ≤ C < 22 %: T; R61-20-36/37-6214 % ≤ C < 20 %: T; R61-20-36-629 % ≤ C < 14 %: T; R61-20-626,5 % ≤ C < 9 %: T; R61-203 % ≤ C < 6,5 %: Xn; R20 
005-018-00-2 perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]perboric acid, sodium salt, tetrahydrate; [2]perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]sodium peroxoborate hexahydrate;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]  - [1]- [2]- [3] 13517-20-9 [1]37244-98-7 [2]10486-00-7 [3] Repr. Cat. 2; R61Repr. Cat. 3; R62Xi; R37-41 TR: 61-37-41-62S: 53-45-47 C ≥ 36 %: T; R61-37-41-6222 % ≤ C < 36 %: T; R61-36/37-6220 % ≤ C < 22 %: T; R61-37-6214 % ≤ C < 20 %: T; R61-6210 % ≤ C < 14 %: T; R61 
005-018-01-X perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]perboric acid, sodium salt, tetrahydrate; [2]perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]sodium peroxoborate hexahydrate;[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] E - [1]- [2]- [3] 13517-20-9 [1]37244-98-7 [2]10486-00-7 [3] Repr. Cat. 2; R61Repr. Cat. 3; R62Xn; R20Xi; R37-41 TR: 61-20-37-41-62S: 53-45-47 C ≥ 36 %: T; R61-20-37-41-6225 % ≤ C < 36 %: T; R61-20-36/37-6222 % ≤ C < 25 %: T; R61-36/37-6220 % ≤ C < 22 %: T; R61-37-6214 % ≤ C < 20 %: T; R61-6210 % ≤ C < 14 %: T; R61 
006-097-00-6 1-phenyl-3-(p-toluenesulfonyl)urea  424-620-1 13909-63-2 Xn; R22-48/22R52-53 XnR: 22-48/22-52/53S: (2-)22-36-61  
006-098-00-1 tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate  429-170-8 134575-17-0 Xn; R22-48/22Xi; R41R43 XnR: 22-41-43-48/22S: (2-)22-26-36/37/39  
006-099-00-7 N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate  432-520-2 232938-43-1 N; R51-53 NR: 51/53S: 22-61  
006-101-00-6 mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea];N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea]  423-070-8 — R53 R: 53S: 61  
006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamate E 432-750-3 — Carc. Cat. 2; R45Muta. Cat. 2; R46Xn; R22-48/22R43N; R51-53 T; NR: 45-46-22-43-48/22-51/53S: 53-45-61  
006-103-00-7 N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea  445-760-8 — Xi; R41R42N; R50-53 Xn; NR: 41-42-50/53S: (2-)22-26-39-45-60-61 C ≥10 %: Xn, N; R41-42-50/535 % ≤ C < 10 %: Xn, N; R36-42-50/531 % ≤ C < 5 %: Xn, N; R42-50/530,25 % ≤ C < 1 %: N; R50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 ≤ C < 0,025 %: R52/53 
007-029-00-8 diethyldimethylammonium hydroxide  419-400-5 95500-19-9 Xn; R21/22C; R35 CR: 21/22-35S: (1/2-)26-36/37/39-45  
012-004-00-X aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate  422-150-1 — N; R50-53 NR: 50/53S: 60-61  
014-036-00-X (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane  405-020-7 105024-66-6 Repr.Cat.2; R60N; R50-53 T; NR: 60-50/53S: 53-45-60-61 C ≥ 0,5 %: T, N; R60-50/530,025 % ≤ C < 0,5 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53 
014-037-00-5 2-butanone-O,O′,O′′-(phenylsilylidyne)trioxime  433-360-6 34036-80-1 Xn; R48/22R43R52-53 XnR: 43-48/22-52/53S: (2-)36/37-61  
014-038-00-0 S-(3-(triethoxysilyl)propyl)octanethioate  436-690-9 220727-26-4 R43 XiR: 43S: (2-)24-37  
014-039-00-6 (2,3-dimethylbut-2-yl)-trimethoxysilane  439-360-2 142877-45-0 Xi; R38-41R52-53 XiR: 38-41-52/53S: (2-)26-37/39-61  
014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane  445-890-5 201290-01-9 Xn; R22R43 XnR: 22-43S: (2-)24-37  
014-042-00-2 mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)  423-010-0 — Xi; R41 XiR: 41S: (2-)26-39  
014-043-00-8 reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)  432-200-2 — F; R11Xi; R37/38-41R52-53 F; XiR: 11-37/38-41-52/53S: (2-)6-26-36/39-61  
014-044-00-3 3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane  433-050-0 — N; R51-53 NR: 51/53S: 61  
014-045-00-9 magnesium sodium fluoride silicate  442-650-1 — Xn; R48/20 XnR: 48/20S: (2-)22-36  
015-190-00-0 bis(2,4-dicumylphenyl) neopentyl diphosphite;3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane  421-920-2 154862-43-8 R53 R: 53S: 61  
015-191-00-6 dodecyldiphenyl phosphate  431-760-5 27460-02-2 Xi; R38R52-53 XiR: 38-52/53S: (2-)37-61  
015-192-00-1 tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate  432-770-2 139189-30-3 R43R53 XiR: 43-53S: (2-)24-37-61  
015-193-00-7 triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)  442-960-7 332350-93-3 T; R25Xi; R41N; R50-53 T; NR: 25-41-50/53S: (1/2-)26-39-45-60-61  
015-194-00-2 tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate  444-440-5 220689-12-3 Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
015-195-00-8 mixture of: potassium o-toluenephosphonate;potassium m-toluenephosphonate;potassium p-toluenephosphonate  433-860-4 — Xi; R36R43R52-53 XiR: 36-43-52/53S: (2-)24-26-37-61  
015-196-00-3 mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate  435-960-3 — Carc.Cat.2; R45Muta.Cat.2; R46R43 TR: 45-46-43S: 53-45  
015-197-00-9 bis(2,4,4-trimethylpentyl)dithiophosphonic acid  420-160-9 107667-02-7 R10T; R23Xn; R22C; R34N; R51-53 T; NR: 10-22-23-34-51/53S: (1/2-)9-26-36/37/39-45-61  
015-198-00-4 (4-phenylbutyl)phosphinic acid  420-450-5 86552-32-1 Carc.Cat.3; R40Xi; R41 XnR: 40-41S: (2-)23-26-36/37/39  
016-094-00-1 sulfur  231-722-6 7704-34-9 Xi; R38 XiR: 38S: (2-)46  
016-097-00-8 1-amino-2-methyl-2-propanethiol hydrochloride  434-480-1 32047-53-3 Xn; R22C; R34R43R52-53 CR: 22-34-43-52/53S: (1/2-)22-26-36/37/39-45-61  
017-009-01-8 ammonium perchlorate;[containing < 80 % of 0-30 μm particles] T 232-235-1 7790-98-9 E; R2O; R9 ER: 2-9S: (2-)14-16-36/37  
022-004-00-1 potassium titanium oxide (K2Ti6O13)  432-240-0 12056-51-8 Carc.Cat.3; R40 XnR: 40S: (2-)22-36/37  
022-005-00-7 [N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium  419-840-8 169104-71-6 F; R11C; R34R43R53 F; CR: 11-34-43-53S: (1/2-)6-9-16-26-36/37/39-45-61  
028-002-01-4 nickel powder;[particle diameter < 1 mm]  231-111-4 7440-02-0 Carc. Cat. 3; R40T; R48/23R43R52-53 TR: 40-43-48/23-52/53S: (2-)36/37/39-45-61  
028-013-00-7 nickel matte E, H 273-749-6 69012-50-6 Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-014-00-2 slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate E 295-859-3 92129-57-2 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23Xn; R20/22Xi; R38R42/43N; R50-53 T; NR: 49-61-20/22-38-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/5320 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/532,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-015-00-8 slimes and sludges, copper electrolyte refining, decopperised E, H 305-433-1 94551-87-8 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 1; R61Repr. Cat. 3; R62T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-62-68-50/53S: 53-45-60-61  
028-016-00-3 nickel diperchlorate;perchloric acid, nickel(II) salt E, H 237-124-1 13637-71-3 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23C; R34R42/43N; R50-53 T; NR: 49-61-34-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/535 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/532,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-017-00-9 nickel dipotassium bis(sulfate); [1]diammonium nickel bis(sulfate) [2] E, H 237-563-9 [1]239-793-2 [2] 13842-46-1 [1]15699-18-0 [2] Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23Xn; R20/22R42/43N; R50-53 T; NR: 49-61-20/22-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-018-00-4 nickel bis(sulfamidate);nickel sulfamate E, H 237-396-1 13770-89-3 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-019-00-X nickel bis(tetrafluoroborate) E, H 238-753-4 14708-14-6 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-021-00-0 nickel diformate; [1]formic acid, nickel salt; [2]formic acid, copper nickel salt [3] E, H 222-101-0 [1]239-946-6 [2]268-755-0 [3] 3349-06-2 [1]15843-02-4 [2]68134-59-8 [3] Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C 0,1 %: Xi; R43 
028-022-00-6 nickel di(acetate); [1]nickel acetate [2] E, H 206-761-7 [1]239-086-1 [2] 373-02-4 [1]14998-37-9 [2] Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23Xn; R20/22R42/43N; R50-53 T; NR: 49-61-20/22-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-024-00-7 nickel dibenzoate E, H 209-046-8 553-71-9 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-025-00-2 nickel bis(4-cyclohexylbutyrate) E, H 223-463-2 3906-55-6 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-026-00-8 nickel(II) stearate;nickel(II) octadecanoate E, H 218-744-1 2223-95-2 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-027-00-3 nickel dilactate E, H — 16039-61-5 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-028-00-9 nickel(II) octanoate E, H 225-656-7 4995-91-9 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat 2; R61T; R48/23C; R35R42/43N; R50-53 T; C; NR: 49-61-35-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/5310 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/535 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/532,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-029-00-4 nickel difluoride; [1]nickel dibromide; [2]nickel diiodide; [3]nickel potassium fluoride [4] E, H 233-071-3 [1]236-665-0 [2]236-666-6 [3]- [4] 10028-18-9 [1]13462-88-9 [2]13462-90-3 [3]11132-10-8 [4] Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-030-00-X nickel hexafluorosilicate E, H 247-430-7 26043-11-8 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-031-00-5 nickel selenate E, H 239-125-2 15060-62-5 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-032-00-0 nickel hydrogen phosphate; [1]nickel bis(dihydrogen phosphate); [2]trinickel bis(orthophosphate); [3]dinickel diphosphate; [4]nickel bis(phosphinate); [5]nickel phosphinate; [6]phosphoric acid, calcium nickel salt; [7]diphosphoric acid, nickel(II) salt [8] E, H 238-278-2 [1]242-522-3 [2]233-844-5 [3]238-426-6 [4]238-511-8 [5]252-840-4 [6]- [7]- [8] 14332-34-4 [1]18718-11-1 [2]10381-36-9 [3]14448-18-1 [4]14507-36-9 [5]36026-88-7 [6]17169-61-8 [7]19372-20-4 [8] Carc. Cat. 1; R49T; R48/23R42/43N; R50-53 T; NR: 49-42/43-48/23-50/53S: 53-45-60-61  
028-033-00-6 diammonium nickel hexacyanoferrate E, H — 74195-78-1 Carc. Cat. 1; R49T; R48/23R42/43N; R50-53 T; NR: 49-42/43-48/23-50/53S: 53-45-60-61  
028-034-00-1 nickel dicyanide E, H 209-160-8 557-19-7 Carc. Cat. 1; R49T; R48/23R42/43R32N; R50-53 T; NR: 49-32-42/43-48/23-50/53S: 53-45-60-61  
028-035-00-7 nickel chromate E, H 238-766-5 14721-18-7 Carc. Cat. 1; R49T; R48/23R42/43N; R50-53 T; NR: 49-42/43-48/23-50/53S: 53-45-60-61  
028-036-00-2 nickel(II) silicate; [1]dinickel orthosilicate; [2]nickel silicate (3:4); [3]silicic acid, nickel salt; [4]trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] E, H 244-578-4 [1]237-411-1 [2]250-788-7 [3]253-461-7 [4]235-688-3 [5] 21784-78-1 [1]13775-54-7 [2]31748-25-1 [3]37321-15-6 [4]12519-85-6 [5] Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-037-00-8 dinickel hexacyanoferrate E, H 238-946-3 14874-78-3 Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-038-00-3 trinickel bis(arsenate);nickel(II) arsenate E, H 236-771-7 13477-70-8 Carc. Cat. 1; R45T; R48/23R43N; R50-53 T; NR: 45-43-48/23-50/53S: 53-45-60-61  
028-039-00-9 nickel oxalate; [1]oxalic acid, nickel salt [2] E, H 208-933-7 [1]243-867-2 [2] 547-67-1 [1]20543-06-0 [2] Carc. Cat. 1; R49T; R48/23R43N: R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-040-00-4 nickel telluride E, H 235-260-6 12142-88-0 Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-041-00-X trinickel tetrasulfide E, H — 12137-12-1 Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-042-00-5 trinickel bis(arsenite) E, H — 74646-29-0 Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-043-00-0 cobalt nickel gray periclase;C.I. Pigment Black 25;C.I. 77332; [1]cobalt nickel dioxide; [2]cobalt nickel oxide [3] E, H 269-051-6 [1]261-346-8 [2]- [3] 68186-89-0 [1]58591-45-0 [2]12737-30-3 [3] Carc. Cat. 1; R49T; R48/23R43 TR: 49-43-48/23S: 53-45  
028-044-00-6 nickel tin trioxide;nickel stannate E, H 234-824-9 12035-38-0 Carc. Cat. 1; R49T; R48/23R43 TR: 49-43-48/23S: 53-45  
028-045-00-1 nickel triuranium decaoxide E, H 239-876-6 15780-33-3 Carc. Cat. 1; R49T; R48/23R43 TR: 49-43-48/23S: 53-45  
028-046-00-7 nickel dithiocyanate E, H 237-205-1 13689-92-4 Carc. Cat. 1; R49Muta. Cat. 3;R68Repr. Cat. 2; R61T; R48/23R42/43R32N; R50-53 T; NR: 49-61-32-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-047-00-2 nickel dichromate E, H 239-646-5 15586-38-6 Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1% ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C 0,1 %: Xi; R43 
028-048-00-8 nickel(II) selenite E, H 233-263-7 10101-96-9 Carc. Cat. 1; R49T; R48/23R42/43N; R50-53 T; NR: 49-42/43-48/23-50/53S: 53-45-60-61  
028-049-00-3 nickel selenide E, H 215-216-2 1314-05-2 Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-050-00-9 silicic acid, lead nickel salt E, H — 68130-19-8 Carc. Cat. 1: R49Repr. Cat. 1: R61Repr. Cat. 3; R62T; R48/23R43N; R50-53 T; NR: 49-61-43-48/23-62-50/53S: 53-45-60-61  
028-051-00-4 nickel diarsenide; [1]nickel arsenide [2] E, H 235-103-1 [1]248-169-1 [2] 12068-61-0 [1]27016-75-7 [2] Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-052-00-X nickel barium titanium primrose priderite;C.I. Pigment Yellow 157;C.I. 77900 E, H 271-853-6 68610-24-2 Carc. Cat. 1: R49T; R48/23R43 TR: 49-43-48/23S: 53-45  
028-053-00-5 nickel dichlorate; [1]nickel dibromate; [2]ethyl hydrogen sulfate, nickel(II) salt [3] E, H 267-897-0 [1]238-596-1 [2]275-897-7 [3] 67952-43-6 [1]14550-87-9 [2]71720-48-4 [3] Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T: R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-054-00-0 nickel(II) trifluoroacetate; [1]nickel(II) propionate; [2]nickel bis(benzenesulfonate); [3]nickel(II) hydrogen citrate; [4]citric acid, ammonium nickel salt; [5]citric acid, nickel salt; [6]nickel bis(2-ethylhexanoate); [7]2-ethylhexanoic acid, nickel salt; [8]dimethylhexanoic acid nickel salt; [9]nickel(II) isooctanoate; [10]nickel isooctanoate; [11]nickel bis(isononanoate); [12]nickel(II) neononanoate; [13]nickel(II) isodecanoate; [14]nickel(II) neodecanoate; [15]neodecanoic acid, nickel salt; [16]nickel(II) neoundecanoate; [17]bis(D-gluconato-O1,O2)nickel; [18]nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]nickel(II) palmitate; [20](2-ethylhexanoato-O)(isononanoato-O)nickel; [21](isononanoato-O)(isooctanoato-O)nickel; [22](isooctanoato-O)(neodecanoato-O)nickel; [23](2-ethylhexanoato-O)(isodecanoato-O)nickel; [24](2-ethylhexanoato-O)(neodecanoato-O)nickel; [25](isodecanoato-O)(isooctanoato-O)nickel; [26](isodecanoato-O)(isononanoato-O)nickel; [27](isononanoato-O)(neodecanoato-O)nickel; [28]fatty acids, C6-19-branched, nickel salts; [29]fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] E, H 240-235-8 [1]222-102-6 [2]254-642-3 [3]242-533-3 [4]242-161-1 [5]245-119-0 [6]224-699-9 [7]231-480-1 [8]301-323-2 [9]249-555-2 [10]248-585-3 [11]284-349-6 [12]300-094-6 [13]287-468-1 [14]287-469-7 [15]257-447-1 [16]300-093-0 [17]276-205-6 [18]258-051-1 [19]237-138-8 [20]287-470-2 [21]287-471-8 [22]284-347-5 [23]284-351-7 [24]285-698-7 [25]285-909-2 [26]284-348-0 [27]287-592-6 [28]294-302-1 [29]283-972-0 [30]- [31] 16083-14-0 [1]3349-08-4 [2]39819-65-3 [3]18721-51-2 [4]18283-82-4 [5]22605-92-1 [6]4454-16-4 [7]7580-31-6 [8]93983-68-7 [9]29317-63-3 [10]27637-46-3 [11]84852-37-9 [12]93920-10-6 [13]85508-43-6 [14]85508-44-7 [15]51818-56-5 [16]93920-09-3 [17]71957-07-8 [18]52625-25-9 [19]13654-40-5 [20]85508-45-8 [21]85508-46-9 [22]84852-35-7 [23]84852-39-1 [24]85135-77-9 [25]85166-19-4 [26]84852-36-8 [27]85551-28-6 [28]91697-41-5 [29]84776-45-4 [30]72319-19-8 [31] Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53 T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61 C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43 
028-055-00-6 nickel(II) sulfite; [1]nickel tellurium trioxide; [2]nickel tellurium tetraoxide; [3]molybdenum nickel hydroxide oxide phosphate [4] E, H 231-827-7 [1]239-967-0 [2]239-974-9 [3]268-585-7 [4] 7757-95-1 [1]15851-52-2 [2]15852-21-8 [3]68130-36-9 [4] Carc. Cat. 1; R49T; R48/23R42/43N; R50-53 T; NR: 49-42/43-48/23-50/53S: 53-45-60-61  
028-056-00-1 nickel boride (NiB); [1]dinickel boride; [2]trinickel boride; [3]nickel boride; [4]dinickel silicide; [5]nickel disilicide; [6]dinickel phosphide; [7]nickel boron phosphide [8] E, H 234-493-0 [1]234-494-6 [2]234-495-1 [3]235-723-2 [4]235-033-1 [5]235-379-3 [6]234-828-0 [7]- [8] 12007-00-0 [1]12007-01-1 [2]12007-02-2 [3]12619-90-8 [4]12059-14-2 [5]12201-89-7 [6]12035-64-2 [7]65229-23-4 [8] Carc. Cat. 1; R49T; R48/23R43N; R50-53 T; NR: 49-43-48/23-50/53S: 53-45-60-61  
028-057-00-7 dialuminium nickel tetraoxide; [1]nickel titanium trioxide; [2]nickel titanium oxide; [3]nickel divanadium hexaoxide; [4]cobalt dimolybdenum nickel octaoxide; [5]nickel zirkonium trioxide; [6]molybdenum nickel tetraoxide; [7]nickel tungsten tetraoxide; [8]olivine, nickel green; [9]lithium nickel dioxide; [10]molybdenum nickel oxide; [11] E, H 234-454-8 [1]234-825-4 [2]235-752-0 [3]257-970-5 [4]268-169-5 [5]274-755-1 [6]238-034-5 [7]238-032-4 [8]271-112-7 [9]- [10]- [11] 12004-35-2 [1]12035-39-1 [2]12653-76-8 [3]52502-12-2 [4]68016-03-5 [5]70692-93-2 [6]14177-55-0 [7]14177-51-6 [8]68515-84-4 [9]12031-65-1 [10]12673-58-4 [11] Carc. Cat. 1; R49T; R48/23R43 TR: 49-43-48/23S: 53-45  
028-058-00-2 cobalt lithium nickel oxide E 442-750-5 — Carc. Cat. 1; R49T+; R26T; R48/23R43N; R50-53 T+; NR: 49-26-43-48/23-50/53S: 53-45-60-61  
029-014-00-5 mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex  419-610-7 171866-24-3 Xn; R48/22N; R51-53 Xn; NR: 48/22-51/53S: (2-)22-36-61  
030-012-00-1 aluminium-magnesium-zinc-carbonate-hydroxide  423-570-6 169314-88-9 R52-53 R: 52/53S: 61  
030-015-00-8 tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate  440-060-9 — N; R51-53 NR: 51/53S: 61  
042-005-00-0 mixture of: mono- and di-glycerols of canola oil;canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];N,N-diorgano dithiocarbamate molybdenum complex  434-240-6 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
050-023-00-5 mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane  422-920-5 — Xn; R48/22N; R50-53 Xn; NR: 48/22-50/53S: (2-)23-36-60-61 C ≥ 10 %: Xn, N; R48/22-50/532,5 % ≤ C < 10 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
050-024-00-0 mixture of: tri-p-tolyltin hydroxide;hexa-p-tolyl-distannoxane  432-230-6 — T; R48/25Xn; R22Xi; R38-41R43N; R50-53 T; NR: 22-38-41-43-48/25-50/53S: (1/2-)22-26-36/37/39-45-60-61  
064-001-00-8 gadolinium(III)sulfite trihydrate  456-900-2 51285-81-5 N; R51-53 NR: 51/53S: 61  
078-011-00-5 hydroxydisulfito platinum(II) acid  423-310-1 61420-92-6 Xn; R22-48/20/21/22C; R35R42/43R52-53 CR: 22-35-42/43-48/20/21/22-52/53S: (1/2-)23-24-26-28-36/37/39-45-61  
078-012-00-0 platinum(IV) nitrate/nitric acid solution  432-400-1 — C; R35N; R50-53 C; NR: 35-50/53S: (1/2-)26-36/37/39-45-60-61  
082-012-00-6 barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped  431-780-4 199876-46-5 Xn; R22-48/22N; R51-53 Xn; NR: 22-48/22-51/53S: (2-)22-36-61  
601-080-00-5 mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;1-(sec-butylphenyl-1-phenylethane, mixed isomers  431-100-6 — N; R50-53 NR: 50/53S: 60-61  
601-081-00-0 cyclohexadeca-1,9-diene  431-730-1 4277-06-9 Xi; R38R43R53 XiR: 38-43-53S: (2-)36/37-61  
601-082-00-6 mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane  434-420-4 — Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)23-26-37/39-57-60-61  
601-083-00-1 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene  435-000-3 22094-83-3 Xn; R65Xi; R38R53 XnR: 38-65-53S: (2-)37-62-61  
601-084-00-7 mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)  435-180-3 — Xn; R65Xi; R38N; R50-53 Xn; NR: 38-65-50/53S: (2-)37-62-60-61  
602-105-00-2 sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate  422-100-7 102061-82-5 Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
602-106-00-8 2-bromo-4,6-difluoroaniline  429-430-0 444-14-4 Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)25-61  
602-107-00-3 3,3,4,4-tetrafluoro-4-iodo-1-butene  439-500-2 33831-83-3 Xn; R22Xi; R38N; R51-53 Xn; NR: 22-38-51/53S: (2-)37-61  
602-108-00-9 (2,3,5,6-tetrafluorophenyl)methanol  443-840-7 4084-38-2 Xn; R22Xi; R36R43 XnR: 22-36-43S: (2-)26-36/37  
603-211-00-1 2,3-epoxypropyltrimethylammonium chloride … %;glycidyl trimethylammonium chloride … % B E 221-221-0 3033-77-0 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62Xn; R21/22-48/22Xi; R41R43R52-53 TR: 45-21/22-41-43-48/22-62-68-52/53S: 53-45-61  
603-212-00-7 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;galaxolide;(HHCB)  214-946-9 1222-05-5 N; R50-53 NR: 50/53S: 60-61  
603-213-00-2 2-methoxy-2-methylbutane;tert-amyl methyl ether  213-611-4 994-05-8 F; R11Xn; R22R67 F; XnR: 11-22-67S: (2-)9-16-23-33  
603-214-00-8 1,1-diisopropoxycyclohexane  413-740-8 1132-95-2 C; R34 CR: 34S: (1/2-)23-26-36/37/39-45  
603-215-00-3 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)  418-330-2 162241-33-0 E; R2Xn; R22-48/22Xi; R41R43N; R50-53 E; Xn; NR: 2-22-41-43-48/22-50/53S: (2-)22-26-36/37/39-60-61  
603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol  422-660-2 7480-35-5 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
603-217-00-4 2,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite  423-560-1 161717-32-4 R43R53 XiR: 43-53S: (2-)24-37/39-61  
603-220-00-0 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol  432-890-5 72955-94-3 R53 R: 53S: 61  
603-221-00-6 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]  433-580-2 214353-17-0 Xn; R22C; R34N; R51-53 C; NR: 22-34-51/53S: (1/2-)26-36/37/39-45-61  
603-221-01-3 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] E 433-580-2 214353-17-0 Carc. Cat. 2; R45Xn; R22C; R34N; R51-53 T; NR: 45-22-34-51/53S: 53-45-61  
603-222-00-1 (2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane  433-820-6 118058-74-5 Xi; R36 XiR: 36S: (2-)26  
603-223-00-7 2-cyclopentylidene cyclopentanol;1,1′-bi(cyclopentyliden)-2-ol  434-270-1 6261-30-9 Xi; R38-41R52-53 XiR: 38-41-52/53S: (2-)26-37/39-61  
603-224-00-2 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane  435-790-1 297730-93-9 R53 R: 53S: 61  
603-225-00-8 erythromycin A9-oxime (E);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)  437-070-0 13127-18-9 N; R51-53 NR: 51/53S: 61  
603-226-00-3 4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol  444-500-0 1440-00-2 R52-53 R: 52/53S: 61  
603-227-00-9 α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate  445-060-2 203574-04-3 O; R7N; R50-53 O; NR: 7-50/53S: (2-)3/7-14-36/37/39-60-61  
603-228-00-4 (+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;6-fluoro-2-(2-oxiranyl)chromane  419-620-1 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)36/37-61  
603-229-00-X sodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate  420-800-7 — Xi; R38-41R43N; R50-53 Xi; NR: 38-41-43-50/53S: (2-)24-26-37/39-60-61  
603-230-00-5 2,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan  440-030-5 — Xi; R38-41R53 XiR: 38-41-53S: (2-)26-37/39-61  
603-231-00-0 (S)-1,1-diphenyl-1,2-propanediol  443-220-6 — R52-53 R: 52/53S: 22-61  
603-232-00-6 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane  444-420-6 — R53 R: 53S: 61  
603-233-00-1 mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol  444-430-0 — N; R51-53 NR: 51/53S: 61  
603-234-00-7 (1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene  444-480-3 — Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
604-074-00-0 tetrabromobisphenol-A;2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol  201-236-9 79-94-7 N; R50-53 NR: 50/53S: 60-61  
604-075-00-6 4-(1,1,3,3-tetramethylbutyl)phenol;4-tert-octylphenol  205-426-2 140-66-9 Xi; R38-41N; R50-53 Xi; NR: 38-41-50/53S: (2-)26-37/39-60-61 C ≥ 20 %: Xi, N; R38-41-50/5310 % ≤ C < 20 %: Xi, N; R41-50/535 % ≤ C < 10 %: Xi, N; R36-50/532,5 % ≤ C < 5 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
604-076-00-1 phenolphthalein  201-004-7 77-09-8 Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62 TR: 45-62-68S: 53-45 C ≥ 5 %: T; R45-62-681 % ≤ C < 5 %: T; R45-68 
604-077-00-7 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol  419-750-9 98809-58-6 R53 R: 53S: 61  
604-079-00-8 4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol  428-970-4 13595-25-0 Repr.Cat.3; R62R43N; R51-53 Xn; NR: 43-62-51/53S: (2-)22-36/37-61  
604-080-00-3 4-fluoro-3-trifluoromethylphenol  432-560-0 61721-07-1 Xn; R20C; R35R43N; R51-53 C; NR: 20-35-43-51/53S: (1/2-)26-28-36/37/39-45-61  
604-081-00-9 1,1-bis(4-hydroxyphenyl)-1-phenylethane  433-130-5 1571-75-1 N; R50-53 NR: 50/53S: 25-60-61  
604-082-00-4 2-chloro-6-fluoro-phenol E 433-890-8 2040-90-6 Muta.Cat.2; R46Repr.Cat.3; R62Xn; R22C; R34R43N; R51-53 T; NR: 46-22-34-43-62-51/53S: 53-45-61  
604-083-00-X 4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol  439-270-3 260408-02-4 R53 R: 53S: 61  
604-084-00-5 1-ethoxy-2,3-difluorobenzene  441-000-4 121219-07-6 Xn; R22R52-53 XnR: 22-52/53S: (2-)23-61  
604-087-00-1 mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol  433-640-8 — F; R17R44R53 FR: 17-44-53S: (2-)15-22-61  
604-089-00-2 2-methyl-5-tert-butylthiophenol  444-970-7 — R10Repr.Cat.3; R63Xn; R48/20/22-65Xi; R36/38R43R67N; R50-53 Xn; NR: 10-36/38-43-48/20/22-63-65-67-50/53S: (2-)26-36/37-62-60-61  
605-037-00-1 trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde  421-800-1 120578-03-2 R53 R: 53S: 22-61  
605-038-00-7 3-methyl-5-phenylpentan-1-al  433-900-0 55066-49-4 Xn; R22Xi; R38R43N; R51-53 Xn; NR: 22-38-43-51/53S: (2-)36/37-61  
605-039-00-2 3,4-dihydroxy-5-nitrobenzaldehyde  441-810-8 116313-85-0 Xn; R22Xi; R41R43 XnR: 22-41-43S: (2-)22-24-26-37/39  
606-124-00-7 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione  421-080-7 161462-35-7 Xn; R48/22N; R50-53 Xn; NR: 48/22-50/53S: (2-)36-60-61  
606-125-00-2 1-benzylimidazolidine-2,4-dione  421-340-1 6777-05-5 Xn; R22 XnR: 22S: (2-)22  
606-126-00-8 1,4-bis(2,3-dihydroxypropylamino)anthraquinone  421-470-7 99788-75-7 N; R51-53 NR: 51/53S: 61  
606-128-00-9 2,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione  422-650-8 148935-94-8 R53 R: 53S: 61  
606-129-00-4 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one  423-090-7 156732-13-7 R53 R: 53S: 61  
606-130-00-X 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone  423-860-2 56309-94-5 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
606-131-00-5 cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione E 427-230-8 5571-36-8 Repr. Cat. 2; R60Xn; R48/22N; R51-53 T; NR: 60-48/22-51/53S: 53-45-61  
606-132-00-0 (6β)-6,19-epoxyandrost-4-ene-3,17-dione  433-490-3 6563-83-3 R43R52-53 XiR: 43-52/53S: (2-)24-37-61  
606-134-00-1 androsta-1,4,9(11)-triene-3,17-dione  433-560-3 15375-21-0 Repr. Cat.3; R62 XnR: 62S: (2-)22-36/37  
606-135-00-7 cyclohexadecanone  438-930-8 2550-52-9 R53 R: 53S: 61  
606-136-00-2 (3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone  444-350-6 133413-70-4 Xi; R36R53 XiR: 36-53S: (2-)26-61  
606-137-00-8 trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione  444-750-0 211387-26-7 R53 R: 53S: 22-61  
606-138-00-3 (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone  444-800-1 141645-23-0 R10Xn; R22-48/22Xi; R38-41R43N; R50-53 Xn; NR: 10-22-38-41-43-48/22-50/53S: (2-)23-26-36/37/39-60-61 C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/5320 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/5310 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/535 % ≤ C < 10 %: Xi, N; R36-43-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
606-139-00-9 (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one  444-830-5 124379-29-9 R53 R: 53S: 61  
606-140-00-4 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one  444-860-9 474510-57-1 Xn; R48/22N; R50-53 Xn; NR: 48/22-50/53S: (2-)22-36-60-61  
606-141-00-X sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate  418-410-7 — Xi; R36 XiR: 36S: (2-)26  
606-142-00-5 mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one  434-290-9 — Xn; R22N; R51-53 Xn; NR: 22-51/53S: (2-)61  
607-580-00-X ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate  422-360-1 100491-29-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)22-24-37-61  
607-618-00-5 menadione sodium bisulfite;2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt  204-987-0 130-37-0 Xi; R36/38N; R50-53 Xi; NR: 36/38-50/53S: (2-)24/25-60-61  
607-619-00-0 menadione nicotinamide bisulfite;1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)  277-543-7 73581-79-0 Xi; R36/38N; R50-53 Xi; NR: 36/38-50/53S: (2-)24/25-60-61  
607-620-00-6 trisodium nitrilotriacetate  225-768-6 5064-31-3 Carc. Cat. 3; R40Xn; R22Xi; R36 XnR: 22-36-40S: (2-)26-36/37-46 C ≥ 25 %: Xn; R22-36-4020 ≤ % C < 25 %: Xn; R36-405 ≤ % C < 20 %: Xn; R40 
607-621-00-1 milbemectin (ISO);[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]  — — Xn; R20/22N; R50-53 Xn; NR: 20/22-50/53S: (2-)46-60-61 C ≥ 25 %: Xn, N; R20/22-50/530,25 % ≤ C < 25 %: N; R50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 % ≤ C < 0,025 %: R52/53 
607-622-00-7 2-ethylhexyl-2-ethylhexanoate  231-057-1 7425-14-1 Repr. Cat. 3; R63 XnR: 63S: (2-)36/37  
607-623-00-2 diisobutyl phthalate  201-553-2 84-69-5 Repr. Cat. 2; R61Repr. Cat. 3; R62 TR: 61-62S: 53-45 C ≥ 25 %: T; R61-625 % ≤ C < 25 %: Xn; R62 
607-624-00-8 perfluorooctane sulfonic acid;heptadecafluorooctane-1-sulfonic acid; [1]potassium perfluorooctanesulfonate;potassium heptadecafluorooctane-1-sulfonate; [2]diethanolamine perfluorooctane sulfonate; [3]ammonium perfluorooctane sulfonate;ammonium heptadecafluorooctanesulfonate; [4]lithium perfluorooctane sulfonate;lithium heptadecafluorooctanesulfonate [5] E 217-179-8 [1]220-527-1 [2]274-460-8 [3]249-415-0 [4]249-644-6 [5] 1763-23-1 [1]2795-39-3 [2]70225-14-8 [3]29081-56-9 [4]29457-72-5 [5] Carc. Cat. 3; R40Repr. Cat. 2; R61T; R48/25Xn; R20/22R64N; R51-53 T; NR: 61-20/22-40-48/25-64-51/53S: 53-45-61  
607-625-00-3 clodinafop-propargyl (ISO)  — 105512-06-9 Xn; R22-48/22R43N; R50-53. Xn; NR: 22-43-48/22-50/53S: (2-)24-36/37-46-60-61 C ≥ 25 %: Xn, N; R22-43-48/22-50/5310 % ≤ C < 25 %: Xn, N; R43-48/22-51/532,5 % ≤ C < 10 %: Xi, N; R43-51/530,25 % ≤ C < 2,5 %: Xi; R43-52/530,001 % ≤ C < 0,25 %: Xi; R43 
607-626-00-9 ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate  401-290-5 103112-35-2 Carc.Cat.2; R45N; R50-53 T; NR: 45-50/53S: 53-45-60-61  
607-627-00-4 [(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate  416-360-0 162221-28-5 R43 XiR: 43S: (2-)22-24-37  
607-628-00-X 4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine  419-240-6 171054-89-0 Xi; R41 XiR: 41S: (2-)26-39  
607-629-00-5 [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid  419-270-1 123599-82-6 Xi; R36 XiR: 36S: (2-)26  
607-630-00-0 acrylic acid, 3-(trimethoxysilyl)propyl ester  419-560-6 4369-14-6 Xn; R20C; R34R43R52-53 CR: 20-34-43-52/53S: (1/2-)26-36/37/39-45-61  
607-631-00-6 mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate  442-300-8 — R43 XiR: 43S: (2-)24-37  
607-632-00-1 N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide  420-210-1 111244-14-5 R53 R: 53S: 61  
607-633-00-7 trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate  440-480-2 341026-59-3 Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
607-634-00-2 (S)-(-)-2-acetoxypropionylchloride;(1S)-2-chloro-1-methyl-2-oxoethyl acetate  420-610-4 36394-75-9 Xn; R22C; R34R43 CR: 22-34-43S: (1/2-)23-26-36/37/39-45  
607-635-00-8 trisodium N-(3-propionato)-L-aspartate  422-090-4 172737-80-3 Xi; R41 XiR: 41S: (2-)26-39  
607-636-00-3 1-bromo-2-methylpropyl propionate  422-900-6 158894-67-8 R10Carc.Cat.3; R40C; R34R43 CR: 10-34-40-43S: (1/2-)7/9-8-23-26-36/37/39-45  
607-637-00-9 disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate  423-730-5 250688-43-8 Xi; R41 XiR: 41S: (2-)26-39  
607-638-00-4 2-hydroxybenzoic acid 2-butyloctyl ester  431-090-3 190085-41-7 R53 R: 53S: 61  
607-639-00-X 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate  431-770-1 216698-07-6 R53 R: 53S: 61  
607-641-00-0 2-(formylamino)-3-thiophenecarboxylic acid;2-formamido-3-thiophenecarboxylic acid  431-930-9 43028-69-9 Xn; R22R43 XnR: 22-43S: (2-)22-24-37  
607-642-00-6 3,6,9-trithiaundecamethylene-1,11-dimethacrylate  432-210-7 141631-22-3 N; R50-53 NR: 50/53S: 60-61  
607-643-00-1 dimethyl (2S)-2-hydroxysuccinate  432-310-0 617-55-0 R10Xi; R41R43 XiR: 10-41-43S: (2-)24-26-37/39-43  
607-644-00-7 methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate  432-350-9 81752-87-6 Xi; R38 XiR: 38S: (2-)37  
607-645-00-2 tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate  432-550-6 243858-01-7 Xi; R41 XiR: 41S: (2-)22-26-39  
607-646-00-8 D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate  432-960-5 124655-09-0 Xn; R22 XnR: 22S: (2-)25  
607-647-00-3 5-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane  433-530-1 143446-73-5 Xn; R22R43N; R50 Xn; NR: 22-43-50S: (2-)24-37-57-61  
607-649-00-4 [3-(chlorocarbonyl)-2-methylphenyl]acetate  433-690-0 167678-46-8 C; R35R43 CR: 35-43S: (1/2-)7/8-26-36/37/39-45  
607-650-00-X 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate  433-910-5 145153-52-2 R43 XiR: 43S: (2-)24-37  
607-651-00-5 sodium 2-(nonanoyloxy)benzenesulfonate  434-360-9 91125-43-8 Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
607-652-00-0 ethyl N2-dodecanoyl-L-argininate hydrochloride  434-630-6 60372-77-2 Xi; R41N; R50 Xi; NR: 41-50S: (2-)26-39-61  
607-653-00-6 tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate  434-840-8 225786-91-4 N; R51-53 NR: 51/53S: 61  
607-654-00-1 (S)-3-hydroxy-γ-butyrolactone  434-990-4 7331-52-4 R43 XiR: 43S: (2-)23-24-37  
607-655-00-7 ethyl 6,8-dichlorooctanoate  435-080-1 1070-64-0 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-656-00-2 sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid  435-350-7 141250-43-3 Xi; R41R52-53 XiR: 41-52/53S: (2-)22-26-39-61  
607-657-00-8 pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate  436-920-8 172399-10-9 Xi; R41 XiR: 41S: (2-)22-26-39  
607-658-00-3 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt  440-770-9 371921-63-0 Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
607-659-00-9 pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid  442-030-0 321912-47-4 Xi; R41 XiR: 41S: (2-)22-26-39  
607-660-00-4 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt  442-230-8 321679-52-1 Xi; R41 XiR: 41S: (2-)22-26-39  
607-661-00-X 1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate  442-850-9 114772-40-6 R43R53 XiR: 43-53S: (2-)22-24-37-61  
607-662-00-5 methyl 2-(acetylamino)-3-chloropropionate  442-860-3 87333-22-0 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-60-61  
607-663-00-0 bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate  442-980-6 127474-91-3 R53 R: 53S: 61  
607-664-00-6 methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate  443-120-2 393509-79-0 Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)26-39-61  
607-665-00-1 trans-methyl-2-ethyl-but-2-enoate  443-150-6 101226-85-1 R10 R: 10S: 23  
607-666-00-7 (2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid  443-560-5 88784-33-2 Xi; R36 XiR: 36S: (2-)26  
607-667-00-2 chloro-1-ethylcyclohexyl carbonate  444-950-8 99464-83-2 Muta.Cat.3; R68R43 XnR: 43-68S: (2-)23-36/37  
607-668-00-8 trans-2-isopropyl-5-carboxy-1,3-dioxane  445-770-2 42031-28-7 Xi; R41R52-53 XiR: 41-52/53S: (2-)22-26-39-61  
607-669-00-3 methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate  445-990-9 376588-17-9 R43R53 XiR: 43-53S: (2-)24-37-61  
607-670-00-9 dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate  448-700-9 500791-70-8 Xn; R48/22Xi; R41R43N; R50-53 Xn; NR: 41-43-48/22-50/53S: (2-)22-26-36/37/39-60-61 C ≥ 10 %: Xn, N; R41-43-48/22-50/535 % ≤ C < 10 %: Xi, N; R36-43-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
607-671-00-4 diethyl 1,4-cyclohexanedicarboxylate  417-310-0 72903-27-6 N; R51-53 NR: 51/53S: 61  
607-672-00-X mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate  419-000-0 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-673-00-5 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate  419-570-0 — Xn; R22R52-53 XnR: 22-52/53S: (2-)61  
607-674-00-0 branched C10-alkyl benzoates  421-090-1 131298-44-7 Xn; R20 XnR: 20S: (2-)23  
607-675-00-6 mixture of: cis-9-octadecenedioic acid;cis-9-cis-12-octadecadienedioic acid;hexadecanedioic acid;octadecanedioic acid  422-260-8 — Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61  
607-676-00-1 mixture of: 2-methylnonanedioic acid;2,4-dimethyl-4-methoxycarbonylundecanedioic acid;2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid  423-670-1 — Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
607-677-00-7 2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate  424-660-8 — Xn; R48/22Xi; R41R43 XnR: 41-43-48/22S: (2-)22-26-36/37/39  
607-678-00-2 mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate  427-090-8 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)23-25-36/37-61  
607-679-00-8 mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)  431-440-5 — Xi; R41N; R51-53 Xi; NR: 41-51/53S: (2-)22-26-39-61  
607-680-00-3 tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate  432-810-9 — R53 R: 53S: 61  
607-681-00-9 mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;dihexadecyl 9-nonyl-10-octylnonadecandioate;1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;dioctadecyl 9-nonyl-10-octylnonadecandioate  432-910-2 — R53 R: 53S: 61  
607-682-00-4 complex mixture of Chinese gum rosin post reacted with acrylic acid  434-230-1 144413-22-9 R53 R: 53S: 61  
607-683-00-X mixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)  435-450-0 — R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
607-684-00-5 alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts  435-660-2 243662-67-1 Xi; R38R43 XiR: 38-43S: (2-)24-37  
607-685-00-0 ammonium 2-cocoyloxyethanesulfonate  441-050-7 — Xi; R38-41 XiR: 38-41S: (2-)26-37/39  
607-686-00-6 6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)  441-550-5 — E; R2F; R11Carc. Cat. 3; R40 E; XnR: 2-11-40S: (2-)7-22-36/37  
607-687-00-1 mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)  442-800-6 — Xi; R38N; R51-53 Xi; NR: 38-51/53S: (2-)37-61  
607-688-00-7 (R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride  444-320-2 — Xn; R22 XnR: 22S: (2-)  
607-689-00-2 mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers)  444-920-4 — R52-53 R: 52/53S: 61  
607-690-00-8 dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate  432-860-1 255387-46-3 R43 XiR: 43S: (2-)24-37  
607-691-00-3 magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear  448-690-6 — R53 R: 53S: 61  
607-692-00-9 zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear  446-470-4 — R53 R: 53S: 61  
607-693-00-4 hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate  443-860-6 302776-68-7 R53 R: 53S: 61  
607-694-00-X ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate  443-870-0 163520-33-0 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)22-36/37-60-61  
608-042-00-7 (S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide  421-810-4 194602-27-2 Xn; R22Xi; R41R43N; R51-53 Xn; NR: 22-41-43-51/53S: (2-)24-26-37/39-61  
608-059-00-X 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile  421-240-6 120068-79-3 N; R51-53 NR: 51/53S: 22-61  
608-060-00-5 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile  421-300-1 138564-59-7 N; R50-53 NR: 50/53S: 22-60-61  
608-062-00-6 2-fluoro-4-hydroxybenzonitrile  422-810-7 82380-18-5 Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)22-26-39-61  
608-063-00-1 (S)-α-hydroxy-3-phenoxy-benzeneacetonitrile  441-070-6 61826-76-4 T; R25Xi; R41R43N; R50-53 T; NR: 25-41-43-50/53S: (1/2-)9-26-36/37/39-45-60-61  
608-064-00-7 cyanomethyltrimethylammoniummethylsulfate  433-720-2 — R52-53 R: 52/53S: 61  
609-069-00-7 musk ketone;3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone  201-328-9 81-14-1 Carc. Cat. 3; R40N; R50-53 Xn; NR: 40-50/53S: (2-)36/37-46-60-61  
611-154-00-9 trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate  403-670-6 92408-46-3 R52-53 R: 52/53S: 61  
611-155-00-4 4,4′-oxybis(benzenesulfonylazide)  431-850-4 7456-68-0 E; R3F; R11Xn; R48/22N; R50-53 E; Xn; NR: 3-11-48/22-50/53S: (2-)14-22-33-35-36-60-61  
611-156-00-X triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate  432-270-4 221354-37-6 Repr. Cat. 3; R62Xn; R48/22N; R51-53 Xn; NR: 48/22-62-51/53S: (2-)36/37-61  
611-157-00-5 benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate  432-590-4 243869-48-9 Xi; R36R52-53 XiR: 36-52/53S: (2-)26-61  
611-158-00-0 reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride  421-520-8 — F; R11R53 FR: 11-53S: (2-)3-12-16-33-61  
611-159-00-6 disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate  421-880-6 — Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
611-160-00-1 mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)  422-760-6 — F; R11R53 FR: 11-53S: (2-)3-12-33-61  
611-161-00-7 trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)  423-100-1 — Xi; R41 XiR: 41S: (2-)26-39  
611-162-00-2 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)  429-600-4 — Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)22-26-39-61  
611-163-00-8 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate  429-610-9 — Xn; R22Xi; R41N; R51-53 Xn; NR: 22-41-51/53S: (2-)22-26-39-61  
611-164-00-3 mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);2,2′-dimethyl-2,2′-azoheptanenitrile;2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)  429-710-2 — R10R32R44Xn; R22N; R51-53 Xn; NR: 10-22-32-44-51/53S: (2-)12-15-16-47-51-61  
611-165-00-9 mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate  431-830-5 — R52-53 R: 52/53S: 61  
611-166-00-4 mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate  432-100-9 — Xi; R41R52-53 XiR: 41-52/53S: (2-)26-39-61  
611-167-00-X sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)  435-240-9 — R52-53 R: 52/53S: 61  
611-168-00-5 mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid  435-440-6 — Xi; R41 XiR: 41S: (2-)22-26-39  
611-169-00-0 sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate  435-800-2 — R52-53 R: 52/53S: 61  
611-170-00-6 mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)  435-880-9 — R52-53 R: 52/53S: 22-61  
611-171-00-1 mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate  436-890-6 — Xi; R41R52-53 XiR: 41-52/53S: (2-)22-26-39-61  
611-172-00-7 mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate  438-310-7 — E; R2Repr. Cat. 3; R62Xn; R22-48/22R52-53 E; XnR: 2-22-48/22-62-52/53S: (2-)22-35-36/37-61  
611-173-00-2 mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt  440-510-4 — Xi; R41R43 XiR: 41-43S: (2-)22-26-36/37/39  
611-174-00-8 mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt  442-290-5 457624-86-1 Xi; R41 XiR: 41S: (2-)22-26-39  
611-175-00-3 mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate  444-050-5 — Xi; R41R52-53 XiR: 41-52/53S: (2-)22-26-39-61  
611-176-00-9 2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate  444-250-2 — E; R2F; R11N; R51-53 E; NR: 2-11-51/53S: (2-)22-61  
611-177-00-4 mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)  444-290-0 508202-43-5 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)22-24-26-37/39-61  
611-178-00-X mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate  445-280-9 — Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)24-26-37/39-61  
611-179-00-5 mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate  450-010-8 — Xi; R41R43 XiR: 41-43S: (2-)22-24-26-37/39  
611-180-00-0 iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts  417-850-7 — N; R51-53 NR: 51/53S: 22-61  
612-238-00-8 (3-chloro-2-hydroxypropyl) trimethylammonium chloride … % B 222-048-3 3327-22-8 Carc. Cat. 3, R40R52-53 XnR: 40-52/53S: 36/37-61  
612-239-00-3 biphenyl-3,3′,4,4′-tetrayltetraamine;diaminobenzidine  202-110-6 91-95-2 Carc. Cat. 2; R45Muta. Cat. 3; R68 TR: 45-68S: 53-45  
612-240-00-9 pyrimethanil (ISO);N-(4,6-dimethylpyrimidin-2-yl)aniline  — 53112-28-0 N; R51-53 NR: 51/53S: 61  
612-241-00-4 piperazine hydrochloride; [1]piperazine dihydrochloride; [2]piperazine phosphate [3]  228-042-7 [1]205-551-2 [2]217-775-8 [3] 6094-40-2 [1]142-64-3 [2]1951-97-9 [3] Repr. Cat. 3; R62-63Xi; R36/38R42/43R52-53 XnR: 36/38-42/43-62-63-52/53S: (1/2-)22-36/37-45-63-61  
612-242-00-X cyprodinil (ISO);4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine  — 121552-61-2 R43N; R50-53 Xi; NR: 43-50/53S: (2-)24-37-46-60-61 C ≥ 2,5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
612-243-00-5 (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate  420-560-3 79617-97-3 Xi; R41N; R50-53 Xi; NR: 41-50/53S: (2-)26-39-60-61 C ≥ 10 %: Xi, N; R41-50/535 % ≤ C < 10 %: Xi, N; R36-50/532,5 % ≤ C < 5 %: N; R50/530,25 % ≤ C < 2, 5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
612-244-00-0 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride  421-310-6 87691-88-1 Repr. Cat. 3; R62Xn; R22Xi; R36R43N; R50-53 Xn; NR: 22-36-43-62-50/53S: (2-)22-26-36/37/39-60-61  
612-245-00-6 2-ethylphenylhydrazine hydrochloride  421-460-2 19398-06-2 Carc. Cat. 3; R40T; R48/25Xn; R22Xi; R41R43N; R50-53 T; NR: 22-40-41-43-48/25-50/53S: (1/2-)22-26-36/37/39-45-60-61 C ≥ 25 %: T, N; R22-40-41-43-48/25-50/5310 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/535 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/532,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/531 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
612-246-00-1 (2-chloroethyl)(3-hydroxypropyl)ammonium chloride E 429-740-6 40722-80-3 Carc. Cat. 2; R45Muta. Cat. 2; R46Xn; R48/22R43R52-53 TR: 45-46-43-48/22-52/53S: 53-45-61  
612-247-00-7 N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide  423-530-8 152828-23-4 T; R48/25Xn; R22R52-53 TR: 22-48/25-52/53S: (1/2-)22-36-45-61  
612-248-00-2 reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)  439-540-0 — Xi; R38R43R53 XiR: 38-43-53S: (2-)24-37-61  
612-249-00-8 4-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride  425-030-5 159939-85-2 Repr. Cat. 3; R62Xn; R22C; R34R43N; R51-53 C; NR: 22-34-43-62-51/53S: (1/2-)22-26-36/37/39-45-61  
612-250-00-3 chloro-N,N-dimethylformiminium chloride E 425-970-6 3724-43-4 R14Repr. Cat. 2; R61Xn; R22C; R35 T; CR: 61-14-22-35S: 53-45  
612-251-00-9 cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride  426-020-3 51229-78-8 F; R11Repr. Cat. 3; R63Xn; R22Xi; R38R43N; R51-53 F; Xn; NR: 11-22-38-43-63-51/53S: (2-)7-22-33-36/37-61  
612-252-00-4 imidacloprid (ISO);1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine  428-040-8 138261-41-3 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)22-57-60-61  
612-253-00-X 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing < 0,5 % formamide (EC No 200-842-0)]  429-400-7 199327-61-2 R52-53 R: R52/53S: 61  
612-253-01-7 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing ≥ 0,5 % formamide (EC No 200-842-0)]  429-400-7 199327-61-2 Repr. Cat. 2; R61R52-53 TR: 61-52/53S: 53-45-61  
612-254-00-5 reaction products of diisopropanolamine with formaldehyde (1:4)  432-440-8 220444-73-5 Carc. Cat. 3; R40Xn; R22C; R34R43N; R51-53 C; NR: 22-34-40-43-51/53S: (1/2-)13-25-26-36/37/39-45-61  
612-255-00-0 1-(3-methoxypropyl)-4-piperidinamine  431-950-8 179474-79-4 Xn; R21/22C; R34R52-53 CR: 21/22-34-52/53S: (1/2-)26-36/37/39-45-61  
612-256-00-6 benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate  427-470-3 137864-22-3 Xn; R22R43 XnR: 22-43S: (2-)36/37  
612-257-00-1 tripropylammonium dihydrogenphosphate  433-700-3 35687-90-2 Xn; R22 XnR: 22S: (2-)22  
612-259-00-2 N-ethyl-3-trimethoxysilyl-2-methyl-propanamine  437-720-3 227085-51-0 Xi; R41 XiR: 41S: (2-)26-39  
612-261-00-3 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline  441-190-9 121451-05-6 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)24-37-60-61 C ≥ 25 %: Xn, N; R22-43-50/532,5 % ≤ C < 25 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
612-265-00-5 bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate  444-360-0 191617-13-7 R52-53 R: 52/53S: 61  
612-266-00-0 3-chloro-4-(3-fluorobenzyloxy)aniline  445-590-4 202197-26-0 Muta. Cat. 3; R68Xn; R22-48/22N; R50-53 Xn; NR: 22-48/22-68-50/53S: (2-)22-36/37-60-61  
612-267-00-6 bis(hydrogenated tallow C16-18-alkyl)hydroxylamine  418-370-0 — R43R53 XiR: 43-53S: (2-)36/37-61  
612-269-00-7 mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline  420-720-2 — R53 R: 53S: 22-61  
612-270-00-2 (S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride  433-010-2 — Xn; R22R43R52-53 XnR: 22-43-52/53S: (2-)22-36/37-61  
612-271-00-8 mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate  434-970-5 160987-57-5 R53 R: 53S: 61  
612-272-00-3 ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate  435-210-5 — N; R51-53 NR: 51/53S: 61  
612-273-00-9 alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride  435-650-8 — Xn; R22C; R35N; R50-53 C; NR: 22-35-50/53S: (1/2-)26-36/37/39-45-60-61  
612-274-00-4 (R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate  445-750-3 — Xn; R22Xi; R41R43R52-53 XnR: 22-41-43-52/53S: (2-)22-24-26-37/39-61  
612-275-00-X fatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil  447-880-6 206565-89-1 Xi; R38-41R43N; R50-53 Xi; NR: 38-41-43-50/53S: (2-)23-26-36/37/39-60-61 C ≥ 20 %: Xi, N; R38-41-43-50/5310 % ≤ C < 20 %: Xi, N; R41-43-50/535 % ≤ C < 10 %: Xi, N; R36-43-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
612-276-00-5 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts  451-430-4 500717-36-2 Xi; R41R43R52-53 XiR: 41-43-52/53S: (2-)22-24-26-36/37/39-61  
612-277-00-0 mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium  451-440-9 586372-44-3 Xi; R41 XiR: 41S: (2-)22-26-39  
612-278-00-6 ethidium bromide;3,8-diamino-1-ethyl-6-phenylphenantridinium bromide  214-984-6 1239-45-8 Muta. Cat. 3; R68T+; R26Xn; R22 T+R: 22-26-68S: (1/2-)28-36/37-45-63  
612-279-00-1 (R,S)-2-amino-3,3-dimethylbutane amide  447-860-7 144177-62-8 Repr. Cat. 3; R62Xn; R48/22Xi; R36/38R43 XnR: 36/38-43-48/22-62S: (2-)22-26-36/37  
612-280-00-7 3-amino-9-ethyl carbazole;9-ethylcarbazol-3-ylamine H 205-057-7 132-32-1 Carc. Cat. 2; R45 TR: 45S: 53-45  
613-116-01-4 tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]  211-986-9 731-27-1 Xi; R36/37/38R43N; R50 Xi; NR: 36/37/38-43-50S: (2-)25-36/37-46-61 C ≥ 20 %: Xi, N; R36/37/38-43-502,5 % ≤ C < 20 %: Xi, N; R43-501 % ≤ C < 2,5 %: Xi; R43 
613-280-00-X tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;dimethyl propyleneurea  230-625-6 7226-23-5 Repr. Cat. 3; R62Xn; R22Xi; R41 XnR: 22-41-62S: 26-36/37/39  
613-281-00-5 quinoline E 202-051-6 91-22-5 Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R21/22Xi; R36/38N; R51-53 T; NR: 45-21/22-36/38-68-51/53S: 53-45-61  
613-282-00-0 triticonazole (ISO);(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol  — 131983-72-7 N; R51-53 NR: 51/53S: 61  
613-283-00-6 ketoconazole;1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone E 265-667-4 65277-42-1 Repr. Cat. 2; R60T; R25Xn; R48/22N; R50-53 T; NR: 60-25-48/22-50/53S: 53-45-60-61  
613-284-00-1 metconazole (ISO);(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol  — 125116-23-6 Repr. Cat. 3; R63Xn; R22N; R51-53 Xn; NR: 22-63-51/53S: (2-)36/37-46-61  
613-285-00-7 1-hydroxybenzotriazole, anhydrous; [1]1-hydroxybenzotriazole, monohydrated [2]  219-989-7 [1]219-989-7 [2] 2592-95-2 [1]123333-53-9 [2] E; R2 ER: 2S: 16-35  
613-286-00-2 potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]  418-260-2 183196-57-8 R43 XiR: 43S: (2-)24-37  
613-286-01-X potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]  418-260-2 183196-57-8 Repr. Cat. 2; R61R43 TR: 61-43S: 53-45  
613-287-00-8 1-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole  419-540-7 160194-26-3 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)24-37-61  
613-288-00-3 1,3-bis(dimethylcarbamoyl)-imidazolium chloride  420-930-4 135756-61-5 Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)22-26-37/39-61  
613-289-00-9 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole  432-020-4 142623-48-1 N; R50-53 NR: 50/53S: 60-61  
613-290-00-4 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride  432-470-1 189012-93-9 Xi; R41R43N; R50-53 Xi; NR: 41-43-50/53S: (2-)24-26-37/39-60-61  
613-291-00-X 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one  434-820-9 106461-41-0 Xn; R48/22N; R50-53 Xn; NR: 48/22-50/53S: (2-)22-36-60-61  
613-292-00-5 N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine  435-010-8 26157-73-3 Muta. Cat. 3; R68R52-53 XnR: 68-52/53S: (2-)36/37-61  
613-293-00-0 2-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester  448-050-6 444065-11-6 R53 R: 53S: 61  
613-294-00-6 2-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester  448-260-8 379268-96-9 R53 R: 53S: 61  
613-295-00-1 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride  448-720-8 363138-44-7 Xn; R22Xi; R41R52-53 XnR: 22-41-52/53S: (2-)22-26-39-61  
613-296-00-7 pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate  418-270-7 — R43R52-53 XiR: 43-52/53S: (2-)24-37-47-61  
613-297-00-2 5-(2-bromophenyl)-2-tert-butyl-2H-tetrazole  420-820-6 — R10Xn; R22N; R51-53 Xn; NR: 10-22-51/53S: (2-)16-61  
613-298-00-8 bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate  421-560-6 — Xn; R48/22Xi; R41N; R51-53 Xn; NR: 41-48/22-51/53S: (2-)22-26-36/39-61  
613-299-00-3 main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt  422-610-1 — Xi; R41 XiR: 41S: (2-)22-26-39  
613-300-00-7 1-imidazol-1-yl-octadecan-2-ol  434-120-3 — R43R53 XiR: 43-53S: (2-)24-37-61  
613-301-00-2 dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate  443-910-7 — R53 R: 53S: 61  
613-302-00-8 disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate  432-980-4 243858-60-8 Xi; R41 XiR: 41S: (2-)22-26-39  
613-303-00-3 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine  429-800-1 95737-68-1 N; R50-53 NR: 50/53S: 60-61  
613-304-00-9 5,6-dihydroxy-2,3-dihydro-1H-indolium bromide  421-170-6 138937-28-7 Xn; R22Xi; R41 XnR: 22-41S: (2-)22-26-39  
613-305-00-4 2-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole  448-630-9 3147-77-1 R53 R: 53S: 61  
613-306-00-X (2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate  433-520-5 82911-69-1 Xn; R22R43N; R51-53 Xn; NR: 22-43-51/53S: (2-)24-37-61  
613-307-00-5 clothianidin (ISO);3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine  — 210880-92-5 Xn; R22N; R50-53 Xn; NR: 22-50/53S: (2-)46-60-61 C ≥ 25 %: Xn, N; R22-50/532,5 % ≤ C < 25 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53 
613-308-00-0 2-amino-5-methylthiazole  423-800-5 7305-71-7 Xn; R22-48/22N; R50-53 Xn; NR: 22-48/22-50/53S: (2-)22-36-60-61  
613-309-00-6 1-methyl-3-phenyl-1-piperazine  431-180-2 5271-27-2 Xn; R21/22Xi; R38-41R52-53 XnR: 21/22-38-41-52/53S: (2-)26-36/37/39-61  
613-310-00-1 (-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride  432-360-3 105813-13-6 Xn; R22R43N; R50-53 Xn; NR: 22-43-50/53S: (2-)22-24-37-60-61  
613-311-00-7 methyl-5-nitrophenyl-guanidine  435-500-1 152460-07-6 Xn; R22Xi; R36R43R52-53 XnR: 22-36-43-52/53S: (2-)22-24-26-37-61  
613-312-00-2 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride  420-200-5 — Xn; R22Xi; R41R43R52-53 XnR: 22-41-43-52/53S: (2-)22-26-36/37/39-61  
613-313-00-8 2-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione  442-780-9 173838-67-0 R52-53 R: 52/53S: 61  
613-314-00-3 4-decyloxazolidin-2-one;4-decyl-1,3-oxazolidin-2-one  443-770-7 7693-82-5 N; R50-53 NR: 50/53S: 22-24-60-61  
613-315-00-9 tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate  430-390-1 — Xn; R20R52-53 XnR: 20-52/53S: (2-)25-61  
613-316-00-4 trimethylopropane tri(3-aziridinylpropanoate);(TAZ) H 257-765-0 52234-82-9 Muta. Cat. 3; R68Xi; R41R43 XnR: 41-43-68S: 26-36/37/39-42  
615-044-00-1 4-chlorophenylisocyanate  203-176-9 104-12-1 T+; R26Xn; R22Xi; R37/38-41R42N; R50-53 T+; NR: 22-26-37/38-41-42-50/53S: (1/2-)26-28-36/37/39-45-63-60-61  
615-045-00-7 4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)  420-530-1 — R42/43R53 XnR: 42/43-53S: (2-)23-24-37-45-61  
616-126-00-X 1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide  423-960-6 139756-01-7 Xn; R22-48/22R52-53 XnR: 22-48/22-52/53S: (2-)22-36/37-61  
616-164-00-7 dimoxystrobin (ISO);(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide  — 149961-52-4 Carc. Cat. 3; R40Repr. Cat. 3; R63Xn; R20N; R50-53 Xn; NR: 20-40-63-50/53S: (2-)36/37-46-60-61 C ≥ 25 %: Xn, N; R20-40-63-50/535 % ≤ C < 25 %: Xn, N; R40-63-50/532,5 % ≤ C < 5 %: Xn, N; R40-50/531 % ≤ C < 2,5 %: Xn, N; R40-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52-53 
616-165-00-2 beflubutamid (ISO);(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide  — 113614-08-7 N; R50-53 NR: 50/53S: 60-61 C ≥ 0,25 %: N; R50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 % ≤ C < 0,025 %: R52/53 
616-166-00-8 cyazofamid (ISO);4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide  — 120116-88-3 N; R50-53 NR: 50/53S: 60-61 C ≥ 2,5 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51-530,025 % ≤ C < 0,25 %: R52/53 
616-167-00-3 N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide  418-290-6 168612-06-4 Xi; R36R43 XiR: 36-43S: (2-)24-26-37  
616-168-00-9 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium  418-440-0 136997-71-2 R43 XiR: 43S: (2-)22-24-37  
616-169-00-4 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one  420-220-4 92771-56-7 R43R53 XiR: 43-53S: (2-)24-37-61  
616-170-00-X (2R)-2-amino-2-phenylacetamide  420-370-0 6485-67-2 Xi; R36R43 XiR: 36-43S: (2-)22-26-36/37  
616-171-00-5 2-(para-chlorophenyl)glycineamide  420-830-0 102333-75-5 Xi; R41R43 XiR: 41-43S: (2-)24-26-37/39  
616-172-00-0 N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl  423-840-3 14691-89-5 Xn; R22 XnR: 22S: (2-)22  
616-174-00-1 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride  424-560-4 151257-01-1 Xn; R22Xi; R36 XnR: 22-36S: (2-)22-26  
616-175-00-7 2-(2-hexyldecyloxy)benzamide  431-230-3 202483-62-3 R53 R: 53S: 61  
616-176-00-2 3-N,N-bis(methoxyethyl)aminoacetanilide  432-530-7 24294-01-7 Xn; R22R52-53 XnR: 22-52/53S: (2-)22-24-61  
616-177-00-8 (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide  432-970-1 217324-98-6 R53 R: 53S: 61  
616-178-00-3 N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide  434-500-9 52583-35-4 R53 R: 53S: 22-61  
616-179-00-9 2-chloro-N-(4-methylphenyl)acetamide  435-170-9 16634-82-5 Xi; R41R43N; R50-53 Xi; NR: 41-43-50/53S: (2-)22-26-36/37/39-60-61  
616-180-00-4 N,N-(dimethylamino)thioacetamide hydrochloride  435-470-1 27366-72-9 Repr. Cat. 2; R61N; R50-53 T; NR: 61-50/53S: 53-45-60-61  
616-181-00-X 4′-methyldodecane-1-sulfonanilide  435-490-9 17417-32-2 N; R50-53 NR: 50/53S: 60-61  
616-182-00-5 N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide  435-860-1 214417-91-1 R43N; R51-53 Xi; NR: 43-51/53S: (2-)24-37-61  
616-183-00-0 N-dodecyl-4-methoxybenzamide  442-340-6 1854-15-5 R53 R: 53S: 61  
616-184-00-6 3-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide  442-560-2 105043-55-8 R53 R: 53S: 61  
616-186-00-7 N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)  443-010-4 53641-10-4 R52-53 R: 52/53S: 61  
616-188-00-8 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide  443-980-9 221215-20-9 R43R53 XiR: 43-53S: (2-)24-37-61  
616-189-00-3 N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide  444-780-4 452962-97-9 R53 R: 53S: 61  
616-190-00-9 N-decyl-4-nitrobenzamide  445-880-0 64026-19-3 R53 R: 53S: 61  
616-191-00-4 2-ethyl-N-methyl-N-(3-methylphenyl)butanamide  446-190-2 406488-30-0 Xn; R22Xi; R36/38R43N; R51-53 Xn; NR: 22-36/38-43-51/53S: (2-)24-26-37-61  
616-192-00-X 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide  448-060-0 727678-39-9 R53 R: 53S: 61  
616-193-00-5 N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide  449-940-7 368450-39-9 R53 R: 53S: 61  
616-194-00-0 2,2-diethoxy-N,N-dimethylacetamide  449-950-1 34640-92-1 Xi; R36 XiR: 36S: (2-)26  
616-196-00-1 disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide  419-990-4 — N; R50-53 NR: 50/53S: 60-61  
616-197-00-7 mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide  422-500-1 — Xn; R48/22 XnR: 48/22S: (2-)22-36  
616-198-00-2 1,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene  423-300-7 — R43R53 XiR: 43-53S: (2-)24-37-61  
616-200-00-1 mixture of: N,N′-ethane-1,2-diylbis(hexanamide);12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide)  432-430-3 — R43R53 XiR: 43-53S: (2-)24-37-61  
616-201-00-7 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine  432-840-2 220926-97-6 Xn; R20R53 XnR: 20-53S: (2-)22-61  
616-202-00-2 mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide  434-330-5 — Carc. Cat. 3; R40R43R53 XnR: 40-43-53S: (2-)36/37-61  
616-203-00-8 mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide  442-280-0 — R53 R: 53S: 61  
616-204-00-3 N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea]  451-060-3 122886-55-9 R53 R: 53S: 61  
617-022-00-7 mixture of: 1,2-dimethylpropylidene dihydroperoxide;dimethyl 1,2-benzenedicarboxylate  442-480-8 — O; R7Xn; R22C; R34R43N; R51-53 O; C; NR: 7-22-34-43-51/53S: (1/2-)3/7-14-26-36/37/39-45-50-61  
647-017-00-5 laccase  420-150-4 80498-15-3 R42 XnR: 42S: (2-)23-45  
ANNEX 1C

The entries in Annex I with the following Index numbers are deleted:
024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.
